⨯

  • 29 Mar 17

Allergy Therapeutics Interim Results 31 Dec

Allergy Therapeutics Interim Results 31 Dec

Allergy Therapeutics plc | AGY | 0 0 0%
Follow Company Follow Company

    • 702 views

 

Allergy Therapeutics Interim Results 31 Dec

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Allergy Therapeutics' set for phase III trial after positive results from grass pollen immunotherapy

Companies: Allergy Therapeutics plc

Alergy Therapeutics: Trading Update July 2020

Companies: Allergy Therapeutics plc

Allergy Therapeutics reveal record pre-R&D operating profit with continued sales growth

Companies: Allergy Therapeutics plc

Successful trial targeting $2bn US allergy market

Companies: Allergy Therapeutics plc

Allergy Therapeutics' hail successful primary outcome of peanut allergy treatment

Companies: Allergy Therapeutics plc

Interim Results

Companies: Allergy Therapeutics plc

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top